Skip Navigation Links
 



                     


 



   
    Learn More     Subscribe    
Join Now!      Login
 
 
 
FREE HEALTH
NEWSLETTER
 
 
Stevia - FDA Poll
Should stevia be approved as a sweetener by the FDA?
 
 
 
 
W
hat Doctors Don't Tell You
 

Misclassification of deaths skews cancer trial results

© What Doctors Don't Tell You (Volume 12, Issue 12)

Analysis of cancer-screening trials has found major inconsistencies in determining deaths due to all causes and deaths due to specific cancers, thereby casting doubt on the value of the findings of these trials.

Researchers from Dartmouth-Hitchcock Medical Center in New Hampshire analysed 12 studies of randomised cancer-screening trials for which data on all-cause and disease-specific mortality were available. Seven were mammography trials, three were faecal occult blood testing and two were chest X-ray screening for lung cancer.

To test the accuracy of the trial findings, the scientists subtracted the disease-specific death rates in the screened populations from those in the controls, and did the same for all-cause mortality rates. They then compared the two different rates of deaths.

Such trials should reveal a greater number of deaths due to specific cancers than from other causes. But, in seven of the 12 trials, there were important inconsistencies. In five of the trials, the differences in the two death rates went in opposite directions, suggesting both positive and negative effects of screening. In four trials, the disease-specific deaths were lower in the screened group than in the controls, but the all-cause mortality was the same or higher in those screened compared with the controls.

In two other trials, while the difference in death rates was more consistent, nevertheless, the difference in all-cause mortality exceeded the disease-specific mortality in the controls.

It is suggested that these differences are mainly the result of biases that led the researchers to misclassify the causes of death.

They recommend that screening trials target those at highest risk because then the ratio of disease-specific to all-cause deaths would be greater than found in the general population. They add that the selection of a high-risk population would also help to avoid the misinterpretation of statistical significance that could make a harmful screening intervention appear to be beneficial or vice versa (J Natl Cancer Inst, 2002; 94: 167-73).

Add your comment      
About The Author
What Doctors Don’t Tell You is one of the few publications in the world that can justifiably claim to solve people's health problems - and even save lives. Our monthly newsletter gives you the facts you won't read anywhere else about what works, what doesn't work and what may harm you in both orthodox and alternative medicine. We'll also tell you how you can prevent illness.......more
Related Articles
 
Share   Facebook   Buzz   Delicious   Digg   Twitter  
 
 
 
 
 
 
From Our Sponsor
 
 
 
 
 
 
Featured Events
Wellness Inventory Certification Training - Level I
     February 18-May 20, 2014
     Los Angeles, CA USA
 
Additional Calendar Links
 
Wellness, Self Responsibility, Love, dimension!

Search   
Home       Wellness       Health A-Z       Alternative Therapies       Find a Practitioner       Healthy Products       Bookstore       Wellness Inventory
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Wellness Center       Nutrition Center       Fitness Center
Free Newsletter      What Doctor's Don't Tell You      Stevia.com      Discount Lab Tests      First Aid      Global Health Calendar      Privacy Policy     Contact Us

Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.